Clofazimine-mediated augmentation of LPS-induced tumor necrosis factor production in macrophages

J G Xiong1, F Minagawa, Y Fukutomi

  • 1National Institute for Leprosy Research, Japan.

Nihon Rai Gakkai Zasshi
|November 1, 1994
PubMed

Insights

Clofazimine enhances lipopolysaccharide-induced tumor necrosis factor (TNF) production in mouse macrophages, boosting immune response. This finding suggests clofazimine

Area of Science:

  • Immunology
  • Microbiology
  • Pharmacology

Background:

  • Tumor necrosis factor (TNF) is crucial for immune responses, particularly against bacterial infections.
  • Clofazimine is an established anti-leprosy medication.
  • The immunomodulatory effects of clofazimine require further elucidation.

Purpose of the Study:

  • To investigate the effect of clofazimine on TNF production in macrophages.
  • To explore the potential of clofazimine in augmenting host immune responses against Mycobacterium leprae.

Main Methods:

  • In vitro study using mouse macrophages.
  • Treatment with clofazimine and rifampicin.
  • Measurement of lipopolysaccharide (LPS)-induced TNF production.

Main Results:

  • Clofazimine treatment augmented LPS-induced TNF production in mouse macrophages.
  • Rifampicin did not exhibit similar TNF-augmenting activity.
  • Clofazimine alone did not induce TNF production.

Conclusions:

  • Clofazimine enhances macrophage cytokine production, potentially improving host defense against M. leprae.
  • The immunomodulatory effect of clofazimine may contribute to its anti-leprosy efficacy.

Related Concept Videos